Dudek, M.; Kałużna-Oleksy, M.; Sawczak, F.; Kukfisz, A.; Soloch, A.; Migaj, J.; Lesiak, M.; Straburzyńska-Migaj, E.
The Usefulness of Soluble ST2 Concentration in Heart Failure with Reduced Ejection Fraction to Predict Severe Impairment in Exercise Capacity Assessed in Cardiopulmonary Exercise Testing. Biomedicines 2025, 13, 60.
https://doi.org/10.3390/biomedicines13010060
AMA Style
Dudek M, Kałużna-Oleksy M, Sawczak F, Kukfisz A, Soloch A, Migaj J, Lesiak M, Straburzyńska-Migaj E.
The Usefulness of Soluble ST2 Concentration in Heart Failure with Reduced Ejection Fraction to Predict Severe Impairment in Exercise Capacity Assessed in Cardiopulmonary Exercise Testing. Biomedicines. 2025; 13(1):60.
https://doi.org/10.3390/biomedicines13010060
Chicago/Turabian Style
Dudek, Magdalena, Marta Kałużna-Oleksy, Filip Sawczak, Agata Kukfisz, Aleksandra Soloch, Jacek Migaj, Maciej Lesiak, and Ewa Straburzyńska-Migaj.
2025. "The Usefulness of Soluble ST2 Concentration in Heart Failure with Reduced Ejection Fraction to Predict Severe Impairment in Exercise Capacity Assessed in Cardiopulmonary Exercise Testing" Biomedicines 13, no. 1: 60.
https://doi.org/10.3390/biomedicines13010060
APA Style
Dudek, M., Kałużna-Oleksy, M., Sawczak, F., Kukfisz, A., Soloch, A., Migaj, J., Lesiak, M., & Straburzyńska-Migaj, E.
(2025). The Usefulness of Soluble ST2 Concentration in Heart Failure with Reduced Ejection Fraction to Predict Severe Impairment in Exercise Capacity Assessed in Cardiopulmonary Exercise Testing. Biomedicines, 13(1), 60.
https://doi.org/10.3390/biomedicines13010060
